Psychologists in Oxford, MS Accepting Medicare

16 Psychologists found. Showing 1 - 16

Mrs. Brandy Baczwaski, M.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 152 Highway 7 South, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-236-3071

Dr. Danielle Maack, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 101 Ricky D Britt Sr Blvd Ste 1b, Oxford, MS 38655 Phone: 662-259-0868

Tammie Maria Hardaway Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 152 Highway 7 S, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-236-3071

Dr. John Young Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 101 Ricky D Britt Sr Blvd, Suite 1-b, Oxford, MS 38655 Phone: 662-380-5031

Dr. Sarah Ann Bilsky, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 511 Deer Creek Dr, Oxford, MS 38655 Phone: 248-240-8003

Mr. Jeffry Scott Bethay, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 34 Private Road 3151, Apartment 7, Oxford, MS 38655 Phone: 662-801-7828

Dr. Scott Allen Gustafson, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 551 Hathorn Rd, Oxford, MS 38655 Phone: 662-915-5272

Dr. Karen Christoff, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 805 Royal Oaks Dr, Oxford, MS 38655 Phone: 662-832-1328

Dr. Penny S. Haws, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1002 Van Buren Ave, Oxford, MS 38655 Phone: 662-234-0511

Ivonne Florez, M.A Psychologist Medicare: Not Enrolled in Medicare Practice Location: 152 Highway 7 S, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-236-3071

Taishiana Desiree' Lover, BA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 152 Highway 7 S, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-236-3071

Dr. Matthew Warren Campbell, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 2005 Harris Dr, Oxford, MS 38655 Phone: 662-513-9936    Fax: 662-513-9937

Dr. Brittany Ann Kinman, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2704 W Oxford Loop Ste 114h, Oxford, MS 38655 Phone: 662-715-7703

Philip G Cooker Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 407 Timber Ln, Oxford, MS 38655 Phone: 662-236-2142

Elizabeth Anneal Dillon, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 152 Highway 7 S, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-236-3071

Dr. Michael Dean Roberts, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 152 Highway 7 S, Oxford, MS 38655 Phone: 662-234-7521    Fax: 662-346-3071

News Archive

Lobectomy for primary lung cancer takes longer in obese patients

Lobectomy for primary lung cancer takes longer when a patient is obese, not only increasing the resources required to achieve a good outcome, but also adding to national health care costs, according to a study published in the December 2012 issue of The Annals of Thoracic Surgery.

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry, shows the potential for increasing the aggressiveness of breast cancer through its behavior as an endocrine-disrupting chemical, a new study finds.

Trubion announces Pfizer's decision to discontinue development of TRU-015 for RA

Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

A three-year, $4.4 million Federal Communications Commission grant will enable UVA Health to expand its Interactive Home Monitoring care for patients with serious and chronic conditions, including COVID-19 and diabetes.

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.

Read more Medical News

› Verified 6 days ago